Skip to main content Accessibility help
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2011
  • Online publication date: January 2011

5 - Measuring quality of life in progressive supranuclear palsy


1. SchragA, Ben ShlomoY, QuinnNP. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 1999; 354: 1771–1775.
2. NathU, Ben ShlomoY, ThomsonRG, et al. The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 2001; 124: 1438–1449.
3. SchragA, SelaiC, DavisJ, LeesAJ, JahanshahiM, QuinnN. Health-related quality of life in patients with progressive supranuclear palsy. Movement Disord 2003; 18: 1464–1469.
4. RichardsonJC, SteeleJ, OlszewskiJ. Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of ‘heterogeneous system degeneration’. Trans Am Neurol Assoc 1963; 88: 25–29.
5. WakabayashiK, TakahashiH. Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration. Neuropathology 2004; 24: 79–86.
6. PapapetropoulosS, GonzalezJ, MashDC. Natural history of progressive supranuclear palsy: a clinicopathologic study from a population of brain donors. Eur Neurol 2005; 54: 1–9.
7. LitvanI, MangoneCA, McKeeA, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996; 60: 615–620.
8. BrusaA, MancardiGL, BugianiO.Progressive supranuclear palsy 1979: an overview. Ital J Neurol Sci 1980; 1: 205–222.
9. MaherER, LeesAJ. The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1986; 36: 1005–1008.
10. WilliamsDR, de SilvaR, PaviourDC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005; 128: 1247–1258.
11. GolbeLI, LeporeFE, JohnsonWG, BelshJM, PowellAL, TreimanDM.Inter-rater reliability of the Progressive Supranuclear Palsy Scale. Neurology 1999; 52(suppl 2): A227.
12. GolbeLI, Ohman-StricklandPA.A clinical ratings scale for progressive supranuclear palsy. Brain 2007; 130(Pt 6): 1552–1565.
13. NunnallyJC, BernsteinIH.Psychometric Theory. 3rd ed. New York: McGraw-Hill, 1994.
14. JuniperEF, GuyattGH, JaeschkeR.How to develop and validate a new health-related quality of life instrument. In: SpilkerB, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, New York: Lippincott-Raven Publishers, 1996.
15. MarxRG, BombardierC, Hogg-JohnsonS, WrightJG.Clinimetric and psychometric strategies for development of a health measurement scale. J Clin Epidemiol 1999; 52: 105–111.
16. StreinerDL, NormanGR.Health Measurement Scales: A Practical Guide to Their Development and Use. Fourth Edition. Oxford: Oxford University Press, 2008.
17. SchragA, SelaiC, QuinnN, LitvanI, LangA, PoonY, BowerJ, BurnD, HobartJ.Measuring quality of life in PSP. Neurology 2006; 67: 39–44.
18. NagataC, IdoM, ShimizuH, MisaoA, MatsuuraH.Choice of response scale for health measurement: comparison of 4, 5, and 7-point scales and visual analog scale. J Epidemiol 1996; 6: 192–197.
19. LitvanI, AgidY, CalneD, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1–9.
20. World Health Organization. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998; 46: 1569–1585.
21. PetoV, JenkinsonC, FitzpatrickR.PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998; 245(suppl 1): S10–S14.
22. The EuroQol Group. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199–208.
23. ZigmondAS, SnaithRP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361–370.